WAEPS 2022 Annual Meeting Physician Program

Question Title

* 1. Please rate the following Thursday (03/10/22) sessions from 1 – 5 (1 =
unsatisfactory; 5 = exemplary).

	1 - unsatisfactory	2 -	3 - Neutral	4 -	5 - Exemplary
Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m.	Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m. 1 - unsatisfactory	Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m. 2 -	Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m. 3 - Neutral	Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m. 4 -	Scientific Presentation: Glaucoma at the Center of the Earth \| Donald Budenz, MD, MPH \| 7:00-7:45 p.m. 5 - Exemplary
Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m.	Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m. 1 - unsatisfactory	Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m. 2 -	Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m. 3 - Neutral	Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m. 4 -	Malpractice Prevention Presentation \| Dan Briceland, MD of OMIC \| 7:45-8:30 p.m. 5 - Exemplary
Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m.	Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m. 1 - unsatisfactory	Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m. 2 -	Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m. 3 - Neutral	Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m. 4 -	Scientific Presentation: Conquering Presbyopia: Are we there yet? \| Sumitra Khandelwal, MD \| 8:30-9:15 p.m. 5 - Exemplary

Question Title

* 2. Please rate the following Friday (03/11/22) sessions from 1 – 5 (1 =
unsatisfactory; 5 = exemplary).

	1 - Unsatisfactory	2 -	3 - Neutral	4 -	5 - Exemplary
Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m.	Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m. 1 - Unsatisfactory	Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m. 2 -	Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m. 3 - Neutral	Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m. 4 -	Scientific Presentation: Bleb Wars: Clinical Pearls from Recent Glaucoma Surgical Trials \| Donald Budenz, MD, MPH \| 8:00-8:25 a.m. 5 - Exemplary
Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m.	Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m. 1 - Unsatisfactory	Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m. 2 -	Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m. 3 - Neutral	Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m. 4 -	Scientific Presentation: Esotropia Associated with Myopia, Heavy Eyes & Sagging Eyes in Adult-onset Strabismus \| David Plager, MD \| 8:25-8:50 a.m. 5 - Exemplary
Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m.	Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m. 1 - Unsatisfactory	Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m. 2 -	Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m. 3 - Neutral	Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m. 4 -	Scientific Presentation: Dry Eye Masquerades \| Sumitra Khandelwal, MD \| 8:50-9:15 a.m. 5 - Exemplary
Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m.	Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m. 1 - Unsatisfactory	Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m. 2 -	Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m. 3 - Neutral	Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m. 4 -	Scientific Presentation: Treatment of Uveitis in 2022 \| Sunil Srivastava, MD \| 9:15-9:40 a.m. 5 - Exemplary
Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m.	Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m. 1 - Unsatisfactory	Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m. 2 -	Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m. 3 - Neutral	Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m. 4 -	Scientific Presentation: Propranolol for Infantile Hemangioma- First Choice for Everyone? \| David Plager, MD \| 10:15-10:35 a.m. 5 - Exemplary
Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m.	Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m. 1 - Unsatisfactory	Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m. 2 -	Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m. 3 - Neutral	Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m. 4 -	Scientific Presentation: IOL Calculations: Long Eyes, Short eyes and Weird Eyes \| Sumitra Khandelwal, MD \| 10:35-10:55 a.m. 5 - Exemplary
Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m.	Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m. 1 - Unsatisfactory	Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m. 2 -	Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m. 3 - Neutral	Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m. 4 -	Scientific Presentation: Surgical Management of the Uveitis Patient \| Sunil Srivastava, MD \| 10:55-11:15 a.m. 5 - Exemplary
Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m.	Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m. 1 - Unsatisfactory	Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m. 2 -	Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m. 3 - Neutral	Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m. 4 -	Scientific Presentation: New Developments in OCT for Glaucoma Diagnosis \| Donald Budenz, MD, MPH \| 11:15-11:40 a.m. 5 - Exemplary
Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m.	Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m. 1 - Unsatisfactory	Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m. 2 -	Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m. 3 - Neutral	Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m. 4 -	Scientific Presentation: Tackling Cataract Complications: Videos \| Sumitra Khandelwal, MD \| 2:00-2:20 p.m. 5 - Exemplary
Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m.	Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m. 1 - Unsatisfactory	Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m. 2 -	Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m. 3 - Neutral	Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m. 4 -	Scientific Presentation: How to Avoid Mistakes in Management of the Uveitis Patient \| Sunil Srivastava, MD \| 2:20-2:40 p.m. 5 - Exemplary
Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m.	Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m. 1 - Unsatisfactory	Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m. 2 -	Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m. 3 - Neutral	Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m. 4 -	Scientific Presentation: Pearls for Visual Field Testing & Interpretation in Glaucoma \| Donald Budenz, MD, MPH \| 2:40-3:00 p.m. 5 - Exemplary
Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m.	Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m. 1 - Unsatisfactory	Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m. 2 -	Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m. 3 - Neutral	Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m. 4 -	Scientific Presentation: Acquired esotropia in children - ominous or no big deal? \| David Plager, MD \| 3:00-3:20 p.m. 5 - Exemplary
Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m.	Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m. 1 - Unsatisfactory	Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m. 2 -	Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m. 3 - Neutral	Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m. 4 -	Scientific Presentation: Five or more interesting uveitis cases \| Sunil Srivastava, MD \| 3:55-4:15 p.m. 5 - Exemplary
Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m.	Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m. 1 - Unsatisfactory	Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m. 2 -	Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m. 3 - Neutral	Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m. 4 -	Scientific Presentation: IOL use in children under age 2 years: What have we learned 1957-2022 \| David Plager, MD \| 4:15-4:35 p.m. 5 - Exemplary
Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m.	Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m. 1 - Unsatisfactory	Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m. 2 -	Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m. 3 - Neutral	Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m. 4 -	Scientific Presentation: Pearls for Premium Lenses \| Sumitra Khandelwal, MD \| 4:35-4:55 p.m. 5 - Exemplary

Question Title

* 3. Having attended the program, rate your ability to:

	No Change	Some Increase	Significant Increase
Use OCT parameter to support the diagnosis of glaucoma.	Use OCT parameter to support the diagnosis of glaucoma. No Change	Use OCT parameter to support the diagnosis of glaucoma. Some Increase	Use OCT parameter to support the diagnosis of glaucoma. Significant Increase
Identify red flags on the pre op evaluation for cataract surgery.	Identify red flags on the pre op evaluation for cataract surgery. No Change	Identify red flags on the pre op evaluation for cataract surgery. Some Increase	Identify red flags on the pre op evaluation for cataract surgery. Significant Increase
Improve outcomes in refractive outcomes in cataract surgery.	Improve outcomes in refractive outcomes in cataract surgery. No Change	Improve outcomes in refractive outcomes in cataract surgery. Some Increase	Improve outcomes in refractive outcomes in cataract surgery. Significant Increase
Manage pre and post op inflammation in uveitis patients.	Manage pre and post op inflammation in uveitis patients. No Change	Manage pre and post op inflammation in uveitis patients. Some Increase	Manage pre and post op inflammation in uveitis patients. Significant Increase
Determine steps in management of patients when initial assessments prove incorrect	Determine steps in management of patients when initial assessments prove incorrect No Change	Determine steps in management of patients when initial assessments prove incorrect Some Increase	Determine steps in management of patients when initial assessments prove incorrect Significant Increase
Identify common artifacts that cause false positive and false negative results in visual fields.	Identify common artifacts that cause false positive and false negative results in visual fields. No Change	Identify common artifacts that cause false positive and false negative results in visual fields. Some Increase	Identify common artifacts that cause false positive and false negative results in visual fields. Significant Increase
Decide which glaucoma surgical patients benefit from a tube vs a trab as primary glaucoma surgery.	Decide which glaucoma surgical patients benefit from a tube vs a trab as primary glaucoma surgery. No Change	Decide which glaucoma surgical patients benefit from a tube vs a trab as primary glaucoma surgery. Some Increase	Decide which glaucoma surgical patients benefit from a tube vs a trab as primary glaucoma surgery. Significant Increase
Be aware of the differential diagnosis of acquired esotropia in children.	Be aware of the differential diagnosis of acquired esotropia in children. No Change	Be aware of the differential diagnosis of acquired esotropia in children. Some Increase	Be aware of the differential diagnosis of acquired esotropia in children. Significant Increase

Question Title

* 4. A "commercial interest" is defined as any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests. Did you perceive any bias toward a "commercial interest" in any presentation?

Yes

No

Question Title

* 5. What patient problems or challenges would you like to see WAEPS address in future CME programs?

Question Title

* 6. Please name at least one change to your practice you will implement as a result of this meeting.

Question Title

* 7. What are the barriers to implementing the competencies learned into your practice?

Question Title

* 8. Next year, what would you like to hear more of?

Question Title

* 9. Next year, what would you like to hear less of?

Question Title

* 10. Any other comments and suggestions to help plan for next year:

Question Title

* 11. I attended this course for ___ total hours of CME credit.

Question Title

* 12. Please enter your name for CME accreditation purposes.

Question Title

* 13. Are you a Washington State Medical Association (WSMA) member?

Yes

No